Expanded programme of immunisation for children

Health and Population; Perspectives and Issues
|December 13, 1978
PubMed

Insights

The Expanded Programme of Immunisation for Children (EPI) ensures adequate funding for child health initiatives. This program highlights the commitment of health administrators to improving pediatric health outcomes through vaccination.

Area of Science:

  • Public Health
  • Pediatrics
  • Health Administration

Background:

  • The Expanded Programme of Immunisation for Children (EPI) is integrated within maternal and child health services.
  • Financial resources for the EPI are guaranteed, ensuring no budgetary constraints.
  • The program serves as a critical indicator of the dedication of medical and health leaders to child welfare.

Purpose of the Study:

  • To provide the background and historical context of the EPI.
  • To outline the recommended immunisation schedule for children.
  • To present a future strategic plan for the EPI.

Main Methods:

  • Literature review of EPI's historical development.
  • Analysis of current recommended childhood immunisation schedules.
  • Strategic planning for future EPI initiatives.

Main Results:

  • The EPI is a well-funded program crucial for child health.
  • A comprehensive immunisation schedule is detailed.
  • Future strategies aim to strengthen child health outcomes.

Conclusions:

  • The EPI is a vital component of child health services with secured funding.
  • Adherence to the recommended immunisation schedule is essential.
  • Future planning will enhance the program's impact on national child health.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...